AVBP
ArriVent BioPharma, Inc.
13.51
+0.02 (+0.11%)
52w low 11.36
35.83 high
8.8% of range
AVBP · 6M
—
O--
H--
L--
C--
Chg--
Gap--
Vol--
×avg--
σ--
SMA20--
SMA50--
SMA200--
RSI--
SPY--
DD--
Bench--
Sig--
Hist--
pinned · Esc to release
hover · click to pin · ← → step · drag to zoom · shift-drag to measure
SMA 20SMA 50
—Context
- Move across the chart.
Events in view
| Date | Kind | Event | Source |
|---|---|---|---|
| 2026-11-09 | filing | 8-K: results of operations (earnings); officer / director change | SEC EDGAR |
| 2026-11-09 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-10-26 | filing | 8-K: Reg FD disclosure; other events | SEC EDGAR |
| 2026-10-19 | filing | 8-K: Reg FD disclosure | SEC EDGAR |
| 2026-10-13 | filing | 8-K: Reg FD disclosure; other events | SEC EDGAR |
| 2026-10-06 | filing | 8-K: Reg FD disclosure; other events | SEC EDGAR |
| 2026-08-12 | filing | 8-K: material agreement; results of operations (earnings) | SEC EDGAR |
| 2026-08-12 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-06-22 | filing | 8-K: shareholder vote | SEC EDGAR |
| 2026-05-11 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-05-11 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-05-11 | filing | 424B5 (prospectus supplement (offering)) | SEC EDGAR |
| 2026-05-11 | filing | 8-K: other events | SEC EDGAR |
Performance
1D
+0.11%
5D
+0.11%
1M
-17.95%
3M
-57.07%
6M
-53.32%
YTD
-32.88%
1Y
-30.31%
2Y
-60.66%
3Y
--
5Y
--
MAX
-37.33%
Period
-54.41%
High
35.83
Low
11.36
Ann Vol
71.45%
Sharpe
-0.74
Max DD
-64.80%
ATR (14)
1.50